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Abstract
Essential tremor (ET) is a commonmovement disorderwith an estimated prevalence of 5% of the population aged over 65 years.
In spite of intensive efforts, the genetic architecture of ET remains unknown. We used a combination of whole-exome
sequencing and targeted resequencing in three ET families. In vitro and in vivo experiments in oligodendrocyte precursor cells
and zebraﬁsh were performed to test our ﬁndings. Whole-exome sequencing revealed a missense mutation in TENM4
segregating in an autosomal-dominant fashion in an ET family. Subsequent targeted resequencing of TENM4 led to the
discovery of two novel missensemutations. Not only did these twomutations segregatewith ET in two additional families, but
we also observed signiﬁcant over transmission of pathogenic TENM4 alleles across the three families. Consistent with a
dominant mode of inheritance, in vitro analysis in oligodendrocyte precursor cells showed that mutant proteins mislocalize.
Finally, expression of human mRNA harboring any of three patient mutations in zebraﬁsh embryos induced defects in axon
guidance, conﬁrming a dominant-negative mode of action for these mutations. Our genetic and functional data, which is
corroborated by the existence of a Tenm4 knockout mouse displaying an ET phenotype, implicates TENM4 in ET. Together with
previous studies of TENM4 in model organisms, our studies intimate that processes regulating myelination in the central
nervous system and axon guidance might be signiﬁcant contributors to the genetic burden of this disorder.
Introduction
Essential tremor (ET [MIM 190300]) is a common hyperkinetic
movement disorder with an estimated prevalence of 1% in the
population. The prevalence increases with age, and 5% of indivi-
duals over 65 years of age are affected (1). ET is typically charac-
terized by rhythmic, involuntary shaking of one or more parts of
the body, and occurs exclusively during voluntary movements
(action tremor) or in positions against gravity (postural tremor)
(2). The phenotypic severity of ET is variable, as evidenced by
the existence of both highly disabling and milder forms of the
disease. ET is considered a complex disorder with a strong genet-
ic component (3,4), since more than half of affected individuals
have a positive family history.
The ﬁrst genetic locus associated with ET was near the
leucine-rich repeat and lg domain containing nogo receptor-
interacting protein 1 gene (LINGO1 [MIM 609791]), identiﬁed by a
genome-wide association study (GWAS) in the Icelandic popula-
tion (5) and replicated in other populations (6). Other studies, in-
cluding several candidate gene association studies and a recent
GWAS (7), revealed potential associations that nonetheless failed
to replicate (4). Additionally, three linkage studies conducted in
large ET families displaying an autosomal-dominant pattern of
inheritance identiﬁed only putative candidate loci, but did not
ﬁnd any underlying disease causing gene(s) (8–10). Factors that
have confounded the identiﬁcation of causal genes include
non-penetrance of ET; a considerable number of misdiagnoses
in the absence of reliable biomarkers; and the existence of pheno-
copies, as distinct sporadic cases may occur within the same
family given the high prevalence in the general population (11).
In this regard, numerous ET families have been reported that are
characterized by an overrepresentation of affected individuals
clearly exceeding the expected 50–50% ratio, which is clearly
beyond the classical pattern of autosomal inheritance (11–13).
The ﬁrst published exome-sequencing study in ET identiﬁed a
causative nonsense mutation in fused in sarcoma (FUS [MIM
137070]) that was segregating with ET in a large pedigree (14).
However, only two additional cases carried other mutations in
the same gene, while independent replication studies uncovered
few additional mutations, suggesting that FUS is a rare cause of
ET (15–18). More recently, a rare variant in HtrA serine peptidase
2 (HTRA2 [MIM 610297]) was shown to cause ET in a large six-
generation family. Interestingly, signs of Parkinson’s disease
(PD) additionally appeared in themiddle age in homozygous car-
riers of this variant (19).
Given the large proportion of familial ET cases without causal
mutations, and the low-to-moderate effect size of the identiﬁed
variant near LINGO1, a large fraction of the heritability of ET re-
mains unexplained. We sought to identify new genes involved
in the pathogenesis of ET by studying orphan ET families by
exome sequencing. Here we describe the identiﬁcation of a new
gene for ET by the combination of exome and targeted resequen-
cing aswell as functional testing using in vitro assays in oligoden-
drocytes precursor cells and in vivo assays in a zebraﬁsh model.
Results
Exome sequencing
The clinical diagnosis of ET was made initially in the index case
(II-5) of a four-generation family (TEF-6) of Spanish origin
(Fig. 1A). The phenotypic severity varied among affected family
members, ranging from a highly disabling to mild tremor (Sup-
plementary Material, Table S1). Given such common phenotypic
variance and transmission of the disease across three genera-
tions, we postulated an autosomal-dominant pattern of inherit-
ance in this family. The available data did not allowus to perform
linkage analysis, mainly due to limited participation and de-
ceased family members. We therefore performed whole-exome
sequencing in four affected family members (II-5, III-2, III-4 and
IV-1) assuming that the disease causing variant is located in
the protein coding region, cognizant of the fact that a mutation
in a regulatory region not captured by this technology cannot
be excluded. After alignment and variant calling, we ﬁrst
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evaluated variants in genes associated previously with auto-
somal-dominant ET and PD (in particular FUS [MIM 137070],
SNCA [MIM 163890], LRRK2 [MIM 609007]). Despite adequate
coverage in these regions, we did not ﬁnd any candidate patho-
genic mutations. We next ﬁltered for single nucleotide variants
(SNVs) and indels that (a) were novel and rare [minor allele fre-
quency (MAF) below 0.5%]; (b) were shared by all four individuals
sequenced and (c)were predicted computationally to be damaging
by Polyphen-2, PROVEAN and CADD (20–22). This yielded a list of
rare alleles in four candidate genes, namely RCOR3, CYTL1 [MIM
607930], E2F8 [MIM 612047] and TENM4 [MIM 610084], all of
which segregated with the disease phenotype in our pedigree.
To avoid bias, we mined expression data for all four genes. We
found that RCOR3, CYTL1 and E2F8 are not expressed appreciably
in neuronal tissues, while subsequent literature searches intimate
an involvement of these transcripts in hepatitis, chondrogenesis
and hepatocellular carcinoma (3,23,24). In contrast, TENM4 is
expressed primarily in the brain and has been detected in several
transcriptomes derived from neuronal tissues (see Materials and
Methods).We alsonoted that Suzuki and colleagues (25) generated
amouse Tenm4 knockoutmodel recently that displays hypomyeli-
nation of small-diameter axons in the CNS anda severe action tre-
mor phenotype (as seen in video by Suzuki et al., http://www.
youtube.com/watch?v=bcmcjLuB_bs). Taken together, this evi-
dence brought our focus to the missense mutation in TENM4
(c.4100C>A) that leads to a threonine-to-asparagine amino acid
substitution (p.T1367N).
The c.4100C>A mutation, which has never been detected
before (absent in 1000 Genomes and EVS), was present in all
affected individuals. We found two healthy offspring in the
fourth generation (IV-2 and IV-3) to be mutation carriers as
well. However, these subjects are <40 years old and are thus likely
presymptomatic carriers that may develop ET, although reduced
penetrance remains a possible scenario. copy number variants
(CNVs) analysis did not yield any genomic rearrangements that
were shared by all four subjects.
Targeted resequencing of TENM4 and segregation
analysis in additional ET families
As a ﬁrst test of the candidacy of TENM4, we asked whether there
might be additional ET families with segregating mutations in
this gene. To this end, we performed targeted resequencing of
TENM4 in 299 index cases of familial ET of Spanish origin (the
mean age of onset = 45 ± 22 years). We recorded all novel mis-
sense, splice-site or nonsense variants with a MAF below 0.1%
according to the EVS and identiﬁed 12 missense mutations, of
which 11 were predicted to be damaging by Polyphen-2 (20) as
well as by PROVEAN and CADD (21,22) (Table 1). DNA samples
were available from additional family members of two mutation
carriers. One of the two families was FET-3, a four-generation
family comprising 11 affected family members (Fig. 1B; Supple-
mentaryMaterial, Table S2). Having identiﬁed the predicteddam-
aging variant c.4324 G>A (p.A1442T) in II-1, we evaluated its
segregation in all available family members. Strikingly, 9 out of
11 affected carried this variant. Targeted resequencing of
TENM4 in III-1 and III-3 excluded other TENM4 mutations, sug-
gesting that these two individuals are potential phenocopies, a
phenomenon observed frequently in ET (13). We also detected
c.4324 G>A in one unaffected offspring in the third generation
(III-7) and another in the fourth generation (IV-2); although
both subjects were reported to be healthy, theymight still develop
the disease at a later age (current age: 42 and 5, respectively).
Nevertheless, reduced penetrance cannot be excluded at this
stage. The second family was a three-generation pedigree, TEF-9,
with ﬁve affected family members (Fig. 1C; Supplementary
Figure 1. Pedigrees of Spanish essential tremor families TEF-6 (A); FET-3 (B) and TEF-9 (C). (Square) male family members. (Circle) female family members, (ﬁlled symbol)
individuals with ET. (*) exome-sequenced individuals. (Dashed symbol) deceased individual. TENM4 genotype status: TEF-6—TENM4 c.4100C>A (C/A = heterozygous
mutant allele); FET-3: TENM4 c.4324 G>A (G/G = homozygous reference allele, G/A = heterozygous mutant allele; TEF-9: TENM4 c.3412G>A (G/G = homozygous reference
allele, G/A = heterozygous mutant allele). If the genetic status is not indicated, the corresponding DNA samples were unavailable.
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Material, Table S3), for three of which we had DNA available. We
found the c.3412G>A variant (p.V1138M) in two of these family
members (II-4 and III-1). The third individual, III-2, did not carry
this mutation, however, in contrast to her siblings, she was not
self-aware of her tremor, which was mild and observed by the
clinician only. Taken together, the segregation and phenotyping
of individuals from threemultigenerational ET pedigrees provided
suggestive evidence of involvement of TENM4 mutations. As an
alternativemeans to test the candidacyof TENM4,we interrogated
the transmission behavior of the discovered alleles. The null
hypothesis (TENM4 alleles transmit randomly) was rejected:
among the 15 parent-affected offspring scorable transmissions
across the three pedigrees, the TENM4mutant allelewas transmit-
ted 12 times, a signiﬁcant departure from50:50 chance (χ2 P < 0.02).
In vitro testing of TENM4 mutations
Our genetic data suggested a causal link between TENM4 variants
and ET. However, because the pathogenic potential of the discov-
ered alleles was predictive, we sought direct evidence. We thus
evaluated the impact of the missense mutations segregating
with ET in our two largest ET pedigrees on subcellular localiza-
tion of TENM4 protein. We transfected Oli-neu cells with expres-
sion vectors containing full-length human TENM4 (wild-type),
negative control c.7933G>A and TENM4 carrying the c.4100C>A,
c.4324 G>A and c.3412G>A mutations. In cells transfected with
wild-type TENM4 and the negative control c.7933G>A, an allele
that has been found in homozygosity in 2/6342 individuals in
EVS, the protein localized homogeneously at the cell membrane.
In contrast, c.4100C>A (p.T1367N), c.4324 G>A (p.A1442T) and
c.3412G>A (p.V1138M) showed clustered TENM4 membrane
localization (Fig. 2).
Modeling of TENM4 in zebraﬁsh
As a second test of allele pathogenicity, as well as a means to de-
termine the direction of effect, we turned to an in vivo zebraﬁsh
model. Given previous ﬁndings of central nervous systemdemye-
lination in a homozygous null Tenm4 mouse model (25), we ﬁrst
assayedmyelin levels in the brain by RNA in situhybridization. In-
jection of either a translation blocking morpholino (tbMO) or a
splice-blocking morpholino (sbMO) (Supplementary Material,
Fig. S1) against the sole endogenous copy of zebraﬁsh tenm4
causedmodest reduction in intensity ofmyelin in the brain, likely
reﬂective of the fact that most, but not all, endogenous tenm4was
suppressed by our MO (data not shown). In contrast, we observed
a signiﬁcant increase in the number of aberrant small-diameter
neuronal axons along the notochord of morphants (either tb or
sbMOs) at 2 days post fertilization (2dpf, Fig. 3A andB). The lesions
observed involved extension andpathﬁnding errors, aswell as ab-
errant branching of the remaining axons, in a pattern reminiscent
of the pathﬁnding defects reported in a Drosophila mutant of the
teneurin/tenascin family (26). The number or neuronal somata
dorsal to the notochord was also compared across control and
morphant embryos, but revealed no differences among the two
groups of animals, suggesting that it is not thenumberor neurons
that is affected but the innervation pattern along the peripheral
nervous system (PNS). The innervation of the truncal muscula-
ture as determined by the neuronal axon aberrationswas rescued
by co-injection of human TENM4 mRNA, demonstrating that the
phenotype was speciﬁc (Fig. 3). These data were encouraging
but, by themselves, did not constitute proof of TENM4 causality,
since they showed only that this transcript/protein is necessary
for axonal guiding functions in the PNS. They did, however,
offer the opportunity to test the effect of the discovered patient
alleles on protein function. We therefore engineered each of the
three mutations and injected them into wild-type zebraﬁsh
embryos. Injection of TENM4mRNA carrying themutations iden-
tiﬁed inTEF-6, FET-3andTEF-9 (c.4100C>A, c.4324G>A, c.3412G>A
and c.7933G>A), but not of thewt construct nor the negative con-
trol high frequency allele c.7933G>A resulted in a phenotype that
phenocopied the one induced by the MO. These data suggested
that these alleles adversely impact the function of the protein
and exert a likely dominant-negative effect (Fig. 3), supporting
our earlier in vitro observations.
Discussion
Here we report pathogenic mutations in TENM4 by exome se-
quencing in a family with ET, followed by the identiﬁcation of
mutations in two additional families. Although the segregation
of the candidate alleles indicates that penetrance is high, in
Table 1 Novel variants (MAF <0.001) found among 300a index cases diagnosed for familial essential tremor
Chromosomal
position
Nucleotide
change
Type of
mutation
Ref.-
allele
Mut.-
allele
MAF in EVS
(Caucasians)
Number of
occurrences in
300 cases
Amino acid
change
Polyphen-2
prediction
11:78780832 c.158G>C M C G NA 1 p.R53P 2
11:78567058 c.1421C>A M G T NA 1 p.A474D 2
11:78565277 c.1553G>A M C T 0.000943 1 p.R518Q 2
11:78443446 c.3053G>A M C T NA 1 p.R1018H 2
11:78440445 c.3382G>A M C T NA 1 p.V1128M 2
11:78437262b c.3412G>A M C T NA 2 p.V1138M 2
11:78419515c c.4100C>A M G T NA 1 p.T1367N 2
11:78413334d c.4324G>A M C T 0 1 p.A1442T 2
11:78413055 c.4603A>C M T G NA 1 p.K1535Q 1
11:78412763 c.4895G>A M C T 0.00048 1 p.R1632H 1
11:78387406 c.5287G>A M C T 0.000942 1 p.G1763R 2
11:78380037 c.7353G>A M C T 0.0006 1 p.M2451I 1
aIncluding the ﬁrst mutation identiﬁed by exome sequencing in TEF-6.
The variant at chromosomal position marked with ‘c’ was segregating in family TEF-6. The variant at chromosomal position marked with ‘d’ was segregating in family
FET-3. The variant at chromosomal position marked with ‘b’ was segregating in family TEF-9. Type of mutations: M =missense. Polyphen-2 prediction: 1 = possibly
damaging, 2 = probably damaging. NA = not applicable. All variants are heterozygous.
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that we did not observe any healthy individuals above the me-
dian age of ET with these mutations, we did identify three likely
phenocopies across two families. This observation is consistent
with recent discussions on the genetic architecture of ET
(11–13), but also of other neurological disorders such as restless
legs syndrome (27), where the presence of phenocopies has
been highlighted as a major confounder in searching for causal
alleles in large multiplex families. At the same time, the term
‘phenocopies’ might also be misleading, as the rate of misdiag-
nosis is known to be high in ET andmany other reported families
are characterized by an overrepresentation of affected indivi-
duals within one pedigree, raising the question whether a rather
more complex genetic architecture should be considered in the
pathogenesis of ET including di- or multigenetic inheritance as
well as epigenetics (11–13). Indeed, the identiﬁcation of a single
causal variant in all six affected siblings in the third generation
of family FET-3 seems unlikely. We also draw attention to the
fact that in other neurological disorders, such as PD, which has
some clinical overlap with ET, the presence of phenocopies is
also a known phenomenon, especially in familial PD caused by
mutations in LRRK2, a well-established cause of this condition
(28). In fact, in ∼14.4% of families with LRRK2 driver mutations,
additional affectedmembers carry the reference alleles only (29).
The Teneurin family of genes (TENM1–TENM4) encodes trans-
membrane proteins that are expressed predominantly in neu-
rons (30). TENM4 is the only member also expressed in the
white matter of the cerebellum of adult mice (31) and was identi-
ﬁed recently as a regulator of oligodendrocyte maturation and
myelination of small-diameter axons in the CNS (25). Interesting-
ly, fractional anisotropy neuroimaging has shown, though not
consistently, white matter abnormalities in different parts of
the brain, particularly in the cerebellum, in ET patients (32). Add-
itionally, teneurins play a major role in motor neuron guidance
and neuronal synapse organization inDrosophila (26) and to affect
neurite outgrowth in neuroblastoma cells (33). Our experiments
in Oli-neu cells as well as our zebraﬁsh experiments concord
with these previous ﬁndings. Notably, the two of the three
TENM4 point mutations assayed in cells (c.4100C>A, c.4324
G>A), are both located in the NHL-repeat/β propeller domain,
which has recently been shown to be crucial for the homophilic
interaction between TENM1 and TENM2 (34). Changes in TENM4
localization may contribute to defects in TENM4-mediated regu-
lation of the phosphorylation of the focal adhesion kinase, which
activates CDC42 and RAC1, two Rho-GTPases that are required for
oligodendroglial process outgrowth (35). Furthermore, our sup-
pression and overexpression experiments in zebraﬁsh show
neuronal pathﬁnding defects, aberrant branching and extension
defects of the small-diameter axons that innervate the truncal
musculature. These are concordant with the aforementioned
studies performed in neuronal cultures and the fruit ﬂy, denoting
that TENM4 is essential for the integrity of the axonal outgrowth
and neuronal innervation patterns. Furthermore, the disease as-
sociation of three of the familial TENM4 mutations, but not the
benign c.7933G>A allele, is supported by the demonstration of a
dominant-negative effect of these alleles. These data also recon-
cile an apparent discrepancy between homozygous (the presence
of tremor) and heterozygous (the absence of tremor) Tenm4
knockout mice: the dominant-negative effect of the discovered
mutations is expected to be more severe than haploinsufﬁciency,
but not as severe as the null phenotype. Similar observations have
been made recently in other disorders and their corresponding
mouse models (36). We are aware that our in vivo functional data
provide only a limited insight into an adult onset phenotype.
Nonetheless, in addition to our zebraﬁsh studies being concordant
with the mouse model, this model organism has been used suc-
cessfully to model other adult onset disorders, including limb
Figure 2. In vitro characterization of the cellular distribution of human TENM4mutants. Localization of wild-type (wt) andmutated forms of TENM4 in Oli-neu cells. Wild-
type TENM4 aswell as the control allele G7933A (c.7933G>A) showed a homogeneousmembrane distribution. In contrast, themutated forms C4100A (c.4100C>A), G4324A
(c.4324 G>A) and G3412A (c.3412G>A) showed clustered localization at the membrane. TENM4 is in red; DAPI nuclear dye is in blue.
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girdle muscular dystrophy (37) and, more relevant to the current
phenotype, restless legs syndrome (38).
In conclusion, we provide several lines of evidence for a new
gene for ET. First,we have identiﬁed three families of Spanish ori-
gin, in which three distinct pathogenic mutations in TENM4 both
segregated with the phenotype and were over-transmitted in
parent–offspring analyses. Second, we showed both in vitro and
in vivo a dominant-negative effect of the identiﬁed mutations.
Third, the existence of a TENM4 knockout mouse displaying a
striking and severe ET phenotype with hypomyelination con-
ﬁrms our ﬁndings that abolished or strongly reduced activity of
TENM4 drives the development of ET by affecting key cellular
processes in the nervous system, and substantiates the identiﬁ-
cation of a major gene in the disease pathogenesis of ET.
Figure 3. Suppression of tenm4 in zebraﬁsh causes defects in motor axon pathﬁnding, outgrowth and branching. (A–H) Lateral views of zebraﬁsh embryos at 2dpf stained
with acetylated tubulin. Inwild-type (wt) embryos (A),motor axons have completedmigration from the periphery, along the commonpath, and extended to themyotome.
In tenm4 morphants (B), secondary axons either fail to migrate along their path (white arrows), exit the periphery but fail to extend, or branch abnormally (asterisks).
Suppression of tenm4 can be partially rescued by co-injection with human wt RNA (C). Overexpression of human Tenm4 wt causes mild pathﬁnding errors (D),
suggesting dose sensitivity for TENM4, Human Tenm4 mutants C4100A (c.4100C>A), G4324A (c.4324 G>A) and G3412A (c.3412G>A), when overexpressed are
signiﬁcantly more severe than TENM4 wt and have similar effects to suppression of tenm4 by MO knockdown (E–G). Overexpression of control allele G7933A
(c.7933G>A) causes mild pathﬁnding errors like overexpression of wt allele (H). (I) Percentage of normal versus abnormal embryos under the conditions being
evaluated above.
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We also show that, given the apparent genetic and phenotyp-
ic confounders in ET, coupling in vitro and in vivo studieswith gen-
omics approaches is critical to improving our ability to interpret
the pathogenic effect of rare candidate alleles. The genetic het-
erogeneity and complex architecture mandate that candidates
such as TENM4 should be investigated in additional families
and larger cohorts. It is worthwhile to note that LINGO1, the
ﬁrst gene found to be consistently associated with ET, is also
known to play an important role in oligodendrocyte maturation
and centralmyelination. Togetherwith thisﬁnding, our data sug-
gest that further studies of oligodendrocyte and axonal guidance
dysfunctionmight extend the catalog of genetic drivers of ET and
help elucidate the genetic architecture of the disease.
Subjects, Materials and Methods
Study design and subjects
All participants included in the study were Europeans of Spanish
origin and provided written informed consent. The study proto-
col was approved by the local ethics committees of the different
hospitals providing the samples. Each patient and unaffected
relative of the three families described here were examined by
movement disorders specialists (the same neurologist for each
family) and diagnoses were made according to the guidelines of
the Consensus Statement of the Movement Disorders Society (2).
Tremor severity was rated by the Fahn, Tolosa and Marin as well
as the Glass scale (39,40). Moreover, the families were pre-
screened for known ET and PD mutations (FUS [MIM 137070],
SNCA [MIM 163890], LRRK2 [MIM 609007], VPS35 [MIM 601501],
PINK1 [MIM 608309] and PARKIN [MIM 602544]).
Exome sequencing
We prepared sequencing libraries using the TruSeq DNA library
preparation kit (Illumina) followed by exome capturing with the
Nimblegen SeqCap EZHumanExomeLibrary v3.0 kit according to
the manufacturers’ protocols. Five single-indexed libraries were
pooled before capturing. We sequenced the multiplexed cap-
tured libraries on a HiSeq2000 (Illumina) resulting in a ﬁnal
mean coverage ranging from 39 to 43-fold and aligned the
paired-end reads (100 bp) to the Human Genome (UCSC hg19)
using bwa (v0.6.2) (41). We then called SNV and indels using
three different software packages (GATK (42), SAMtools (43) and
SHORE (44)), annotated the variants with ANNOVAR (45) and
intersected the output of the three calling programs to obtain a
reliable set of variants. After selecting for variants shared by all
affected individuals, and establishing population frequency for
each variant from the 1000 Genomes database and the Exome
Variant Server (46,47), we applied the following ﬁltering steps
to obtain a ﬁnal list of candidate variants: we focused on non-
synonymous, splice-site, nonsense and frameshift variants,
and performed in silico predictions of the damaging potential of
each candidate variant using Polymorphism Phenotyping ver-
sion 2 (Polyphen-2), Protein Variation Effect Analyzer (PROVEAN)
and Combined Annotation Dependent Depletion (CADD) (20–22).
We also analyzed the exome data for CNV with Conifer (48).
Targeted resequencing
Weapplied a recently publishedmethod based on the design and
usage of molecular inversion probes (MIP) which allows high-
throughput resequencing of loci of interest at low cost (49).
MIPs were designed to target the coding region of TENM4 [MIM
610084] (probe sequences available on request). After pooling
and 5′-phosphorylation, MIPs were hybridized to genomic DNA,
followed by gap-ﬁlling and circularization. Capture circles were
ampliﬁed by polymerase chain reaction (PCR) where the Illumina
sequencing adaptor and one of 384 sample speciﬁc barcodeswere
appended. After cleanup and pooling of up to 384 single-indexed
samples, multiplexed libraries were sequenced on a MiSeq (Illu-
mina) using 150 bp paired-end reads. Paired-end reads were col-
lapsed to one single read with FLASH (50) to reduce potential
sequencing errors. Alignment, variant calling and ﬁltering fol-
lowed the same pipeline as exome sequencing. Identiﬁed novel
variants (MAF <0.001) were validated by Sanger sequencing (pri-
mer sequences available on request).
Production of anti-TENM4 antibodies
A recombinant fusion protein between the Tenascin-C signal
peptide and the human teneurin-4 EGF-like repeats was gener-
ated by splicing by overlap extension. The resulting PCR fragment
was cloned into the expression vector pCEP4 (Invitrogen) and
transfected into HEK293 EBNA cells. The recombinant protein
was puriﬁed from the tissue culture medium using the Probond
Puriﬁcation System (Invitrogen) and sent for injection into rab-
bits to generate polyclonal antibodies. The antibodieswere tested
to recognize the recombinant protein as well as the endogenous
TENM4 protein in tissue lysates. Using human glioblastoma pro-
tein lysates on western blots, the anti-TENM4 antiserum de-
tected a single band above 200 kDa, which was not detectable
anymore after preabsorption of the antiserum with the recom-
binant TENM4 protein used for immunization (not shown).
TENM4 cloning and transfection
We PCR-ampliﬁed TENM4 from a human brain cDNA library
(Clonetech) and cloned the product into pcDNA 3.1 (Invitrogen).
Sanger sequencing validation of the vector uncovered eight
synonymous changes and seven point mutations that we retro-
mutated using site-directed in vitromutagenesis (Agilent). We gen-
erated TENM4 c.4100C>A, c.4324 G>A, c.3412G>A and c.7933G>A
mutants using the same strategy. Murine oligodendroglial precur-
sor cells (Oli-neu) were transfected with wild-type and mutant
TENM4 as described (51). Cells were ﬁxed in phosphate-buffered
saline containing 4% paraformaldehyde, permeabilized with 0.1%
Triton and blocked with 5% goat serum. Cells were then incubated
overnight with the primary antiserum (rabbit anti-hTENM4) in
2.5% goat serum followed by goat anti-rabbit-biotin-conjugated
and by goat anti-rabbit-streptavidin-Cy3 (Jackson Immunoresearch
Laboratories). Nuclei were counterstained with 4’,6-diamidino-2-
phenylindole (DAPI) and preparations were analyzed with a Leica
SP5 AOBS confocal microscope.
In silico analysis of ET candidates
Expression proﬁles for RCOR3, CYTL1 [MIM 607930], E2F8 [MIM
612047] and TENM4 [MIM 610084] were obtained from the BioGPS
database (52). Information on the speciﬁc tissues inwhich each of
these genes is detected was retrieved from AceView (53).
Zebraﬁsh functional assay
We used reciprocal BLAST against the Danio rerio genome and
identiﬁed a sole zebraﬁsh ortholog of TENM4 (ENSDARG00000
034264, 87% similarity, 77% identity). To determine the effect of
tenm4 suppression in zebraﬁsh embryos, two morpholinos (MO)
were designed and obtained from Gene Tools, LLC (Philomath,
OR, USA), tenm4 tbMO (AGGGTCTGCGTTCCTTGACTTCCAT),
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targeting the translation site and tenm4 sbMO (ATGCGGTTTCA-
TACTAACCGATTGC), targeting the splice junction at the 3′ end
of exon 10. To determine MO efﬁciency, total mRNA was ex-
tracted from control and MO-injected embryos, reverse-tran-
scribed to produce cDNA and the site targeted by the MO was
PCR ampliﬁed using the following primers: GGAGGTCG-
CAGGTCTTTATTG and CTGCAGTCGGGTCCTCTGAAGC, as de-
scribed (54).
For zebraﬁsh injections, capped human TENM4 mRNA was
produced by cloning wild-type TENM4 (NM_001098816.2) cDNA
and the four mutant constructs (c.4100C>A, c.4324 G>A,
c.3412G>A and c.7933G>A) into the pCS2+ expression vector
and reverse transcribing each construct in vitrowith the T7 Mes-
sage Machine kit (Ambion).
All experiments were carried out with the approval of the In-
stitutional Animal Care and Use Committee. Zebraﬁsh were
maintained and mated according to standard procedures (55).
For knockdown and rescue experiments, we injected 10 ng of
sbMO, and/or 10 pg human mRNA into zebraﬁsh embryos at 1–4
cell stage. Injected embryos were ﬁxed at 2 dpf and were stained
with anti-α acetylated tubulin primary antibody as described (56).
The integrity of the PNS was evaluated by scoring embryos for
motor neuron abnormalities involving pathﬁnding errors, abnor-
mal branching and failure to extend. All the experimentswere re-
peated three times and a Pearson’s chi-square test (χ2) was used
to determine the signiﬁcance.
For in situ analysis, amyelin basic protein (mbp) probewas de-
signed using the following primers: AATTAACCCTCACTAAAG
GGGCCACTGCAAGCACCTCTGG and TAATACGACTCACTATAG
GACGAGGAGAGGACACAAAGC. RNA in situ hybridization was
performed as described (57).
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